Komori
Osaka Soda (4046) · InitiativeFirst statedLatest Revisions to earnings forecasts (2026-08-07): "Advanced"

Functional Research and Human Trials for Plant-Based Lactic Acid Bacteria OS-1010

First written in FY2026-H1. 2 of 3 entries say "Advanced", first in 2026-05-12. Latest entry: 2026-08-07.

3entries
2years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2026-H1Advanced2026-05-12 – 2026-08-072025: 120252026: 22026
Same theme, other companies
Health Technology Research Based on Yeast, Lactic Acid Bacteria and the Gut MicrobiomeA theme 5 companies write about · 0 as a headwind · 5 as a tailwind

4 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  2. FY2026-H1First statedAnnual report

    「For plant-derived lactic acid bacterium OS-1010, human trials relating to maintaining cognitive function and other effects are progressing smoothly, following its function in maintaining skin elasticity.」

    植物性乳酸菌OS-1010について、肌の弾力維持機能に続き、認知機能維持等に関するヒト試験を進めていることを新たに記載している。
Moved together

"Achieving ¥30 Billion in Operating Profit in FY2030 under the Ninth Medium-Term Management Plan “Transform Our Future 2030”" moved the same way as this thread, in the same document, in 2 of its 3 moves.

2222★1234
  1. ★This thread
  2. 1Achieving ¥30 Billion in Operating Profit in FY2030 under the Ninth Medium-Term Management Plan “Transform Our Future 2030”2×
  3. 2Shareholder Returns and Improved Capital Efficiency through Share Repurchases2×
  4. 3Developing Healthcare-Related Businesses into a Third Earnings Pillar2×
  5. 4Expansion of sales of pharmaceutical purification materials and active pharmaceutical ingredient intermediates, along with increased production capacity and enhanced specialized equipment2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Osaka Soda yet. It last moved in the Revisions to earnings forecasts of 2026-08-07: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Functional Research and Human Trials for Plant-Based Lactic Acid Bacteria OS-1010 | OSAKA SODA CO.,LTD. (4046) | Komori